Table 2 Etiological classification of patients with a history of uveitis infected with COVID-19
Etiology (n, %) | Total (n = 288) | Relapsed patients | Non-relapsed |
|---|---|---|---|
(n = 83) | patients (n = 205) | ||
Vogt-Koyanagi-Harada disease | 47 (16.3) | 14 (16.9) | 33 (16.1) |
Behcet’s disease-related uveitis | 26 (9.0) | 4 (4.8) | 22 (10.7) |
Ankylosing spondylitis associated uveitis | 19 (6.6) | 9 (10.8) | 10 (4.9) |
Other systemic diseases-related uveitisa | 16 (5.6) | 6 (7.2) | 10 (4.9) |
Viral anterior uveitis | 4 (1.4) | 1 (1.2) | 3 (1.5) |
Fuchs’ heterochromic iridocyclitis | 4 (1.4) | 1 (1.2) | 3 (1.5) |
Cytomegalovirus retinitis | 2 (0.7) | 0 | 2 (1.0) |
Acute retinal necrosis syndrome | 2 (0.7) | 0 | 2 (1.0) |
Posner-Schlossman Syndrome | 2 (0.7) | 0 | 2 (1.0) |
Toxoplasmosis | 1(0.3) | 0 | 1 (0.5) |
Idiopathic uveitis | 165 (57.3) | 48 (57.8) | 117 (57.1) |